1-4 of 4
Steven Tsai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax (VEN) and azacitidine (AZA) with gilteritinib (GILT) in patients with newly diagnosed (ND) FLT3mut+ Acute Myeloid Leukemia (AML) ineligible for intensive induction chemotherapy (chemo): Interim results from the phase 1/2 VICEROY study

Free
Jessica Altman, Alexander Perl, Eunice Wang, Uma Borate, Elie Traer, James Dugan, Margaret Kasner, Richard Larson, Yehuda Deutsch, Aditi Shastri, Maria Baer, Steven Tsai, Deepa Jeyakumar, Hoda Pourhassan, Alireza Eghtedar, Caroline Chen, Alexandra Heinloth, Rishita Nuthethi, Stanley Gill, Jason Hill, Nahla Hasabou, Mark Levis, Naval Daver
Journal: Blood
Blood (2025) 146 (Supplement 1): 654.
https://doi.org/10.1182/blood-2025-654
Published: 2025
Journal Articles

Trial in Progress: Cureaa - a Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia, Blood and Marrow Transplant Clinical Trials Network (BMT CTN) #2207

Free
Akshay Sharma, Abhishek A. Mangaonkar, Adetola A. Kassim, Amber R. Fritz, Anna Bellach, Blachy J Davila Saldana, Brian J. Ball, Craig Malmberg, Daria V Babushok, Lori Henderson, Manu Pandey, Michael J Martens, Nancy DiFronzo, Nancy Geller, Nicole M. Ritzau, Sagar S. Patel, Srinivasa Reddy Sanikommu, Steven M. Devine, Steven Tsai, Larisa Broglie, Mary M. Horowitz, Sally Arai, Amy E. DeZern
Journal: Blood
Blood (2024) 144 (Supplement 1): 2134.1.
https://doi.org/10.1182/blood-2024-207952
Published: 2024
Journal Articles

Trial in Progress: Tagraxofusp-Based Therapy to Eradicate Measurable Residual Disease of Acute Myelogenous Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation

Free
Daria Gaut, Caspian Oliai, Steven Tsai, Chi-Hong Tseng, Aaron C. Logan, Gary J. Schiller
Journal: Blood
Blood (2022) 140 (Supplement 1): 6230–6232.
https://doi.org/10.1182/blood-2022-164721
Published: 2022
Journal Articles

Trial in Progress: Acalabrutinib Maintenance Following Cellular Therapy for Large B-Cell Lymphoma Patients at High Risk for Relapse

Free
Daria Gaut, Caspian Oliai, Steven Tsai, Chiung-Yu Huang, Joseph Tuscano, Herbert Eradat, Gary J. Schiller
Journal: Blood
Blood (2022) 140 (Supplement 1): 12735–12736.
https://doi.org/10.1182/blood-2022-157466
Published: 2022